Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287711 · ClinicalTrials.gov registry record · NA
Adjunctive Motivational Alcohol Intervention to Prevent IPV
A NA study of Alcohol Use and Intimate Partner Violence, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT05287711: Recruiting NA study of Alcohol Use and Intimate Partner Violence, sponsored by VA Office of Research and Development.
NCT05287711 is a NA study of Alcohol Use and Intimate Partner Violence that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05287711, a NA study of Alcohol Use and Intimate Partner Violence, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a study to provide much-needed experimental data on the efficacy of a brief alcohol Motivational Enhancement Therapy (MET) pre-group intervention for Veterans receiving group treatment for IPV perpetration. The investigators will compare those assigned to receive this 2-session MET intervention to those receiving a 2-session Alcohol Education (AE) intervention or a 2-session standard treatment as usual (TAU) telephone monitoring intervention. The investigators will examine whether MET leads to greater reductions in alcohol use problems and IPV perpetration, and increased help-seeking behavior for alcohol use problems. Participants will be 300 Veterans drawn from the Strength at Home IPV intervention program across the entire Veterans Health Administration system.
Primary Outcome
Participants will be shown a standard drink equivalent chart and will answer questions about their typical alcohol consumption quantity (in standard drink units) on weekdays and weekend days, typical drinking frequency (number of consumption days per week) on weekdays and weekend days, and the highest number of standard drinks consumed at a single occasion during the prior 3 months. If participants work unusual schedules, they will be asked to define the weekend as their day or days off from wor
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Motivational Enhancement Therapy
- BEHAVIORAL Alcohol Education Control
- BEHAVIORAL Strength at Home
Study Locations (3)
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
Michigan
- VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor
Minnesota
- Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2028-09-30 |
| Phase | NA |
What NCT05287711 shows while recruiting
NCT05287711 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Alcohol Use and Intimate Partner Violence appearing as the primary indexed condition, and to 4 interventions - of which Treatment as Usual is the first listed.
NCT05287711 reports a single indexed study location in Massachusetts, Michigan, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05287711 about?
NCT05287711 is a clinical study titled "Adjunctive Motivational Alcohol Intervention to Prevent IPV". This is a study to provide much-needed experimental data on the efficacy of a brief alcohol Motivational Enhancement Therapy (MET) pre-group intervention for Veterans receiving group treatment for IPV perpetration. The investigators will compare those assigned to receive this 2-session MET intervent...
What is the current status of trial NCT05287711?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-09-01. Estimated completion is 2028-09-30.
What conditions does trial NCT05287711 study?
This clinical trial studies the following conditions: Alcohol Use and Intimate Partner Violence.
What interventions are being tested in trial NCT05287711?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Motivational Enhancement Therapy (BEHAVIORAL), Alcohol Education Control (BEHAVIORAL), Strength at Home (BEHAVIORAL).
Who is sponsoring clinical trial NCT05287711?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287711 being conducted?
This trial has 3 study locations across Massachusetts, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05287711's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI